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In France, there are 49 specialized CF centres. In each one there are coordinating
nurses. One of their tasks is to organize the intravenous antibiotic treatment at
home for patients, with the homecare nurses. In November 2006, a group of 18
coordinating nurses of the “West French CF Network” was created representing
3 regions and 10 adult or paediatric CF centres for a total of 853 followed up
patients. A senior coordinator is responsible for organizing meetings, projects
management and reporting, 3 times a year. After an initial meeting, the group
has listed various work tracks. The intravenous antibiotic treatment on implantable
catheter port (ICP) has been prioritized by voting. A questionnaire survey about the
coordinating nurses’ care practices was initially conducted. The results showed that
no coordinating nurse had the same practices. The common was using syringes
10ml on ICP. Therefore, the group decided to create common protocols for
the homecare nurses, in light of national guidelines of ICP. This meant for each
coordinating nurse to review its own practices of care, to change and organize the
change: many discussions during meetings with respect and listening to others,
help of a specialist nurse in hygiene and a specialized lab. The protocols have
been written and tested. Some homecare nurses have reviewed them and provided
feedback. Then protocols have been validated by CClin (regional specialists in
hygiene in health). Today these protocols are implanted in each centre, for the
homecare. The change is gradual and easier to set on with the homecare nurses
newly trained. To assess the impact of this work, the original investigation will be
renewed in 2011.
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Background: IV antibiotic courses are organized at home with elastomeric dif-
fusers (ED) in our adult CF patients. Many patients have indicated that ED were
empty after or before the expected time for the infusion. This may disorganize
homecare or increase the risk of venous access devices (VAD) occlusion because
nurses cannot ﬂush them on time. The mean ﬂow rate (Q) variance is speciﬁed in
ISO28620. Q is linked to venous pressure, infusing pressure and hydraulic resistance
of the device. An inﬂatable cuff, made of silicone (Si) or polyisoprene (Pi), is the
source of the infusing pressure.
Aim of the study: To compare the brands of ED and to evaluate the performance
of 2 types of inﬂatable cuff at 5, 10 and 200mL/h. Furthermore tests were
repeated with various counter pressures in order to simulate physiological cough.
An experimental bench was designed. The volume of water to ﬁll the cuffs respected
manufacturer’s instructions. The instant Q was measured at regular time intervals
until cuffs were emptied.
Results: For cuffs in Pi, instant Qs are close to nominal Q with 2 peaks of over ﬂow,
at the start and at the end of infusion time. This last one is followed by a rapid
decrease of the ﬂow allowing blood to ﬂow back into VADs. With Si, measured Qs
are lower than nominal Q and furthermore decrease constantly. As a result infusion
time increases over 50%. The results are in line with hemodynamic laws: one cannot
determine Q and pressure together. The speciﬁc result of each material is linked
to the mechanical properties of each polymer. However, even Si cuff performances
remain within the norm. Among ED, the one using Pi for the cuff should be
preferred.
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Objective: There is evidence that health beliefs can inﬂuence treatment adherence in
cystic ﬁbrosis (CF). This work evaluated Horne’s Necessity–Concerns Framework.
The framework states that treatment adherence is associated with the way in which
a person perceives their personal need for a therapy relative to their concerns
regarding its adverse effects.
Methods: Participants completed the Beliefs about Medicines Scale (BMS) and
a CF Adherence Scale. The BMS generates four attitudinal groups according to
how necessary a person believes their therapy to be combined with their degree of
concern: Accepting (high necessity, low concerns), Ambivalent (high necessity, high
concerns), Sceptical (low necessity, high concerns) and Indifferent (low necessity,
low concerns). Clinical and demographic data were also recorded.
Results: 196 adults (45% male) consented to take part in the study. Their mean age
and FEV1 % predicted were 26 years and 60% respectively. 27.6% were categorized
as Accepting, 29.6% Ambivalent, 21.4% Sceptical and 21.4% Indifferent. Those
who were Accepting were less adherent to oral, nebulised and IV antibiotics than
those who were Ambivalent. Those who were Sceptical were also more non-adherent
than those who were Ambivalent or Indifferent to oral antibiotics. Similarly for
enzymes, vitamins and nutritional supplements those who were either Accepting
or Sceptical reported poor adherence. No group differences emerged for other
therapies.
Conclusion: Interventions aimed at intentional non-adherence need to recognize the
ways in which people appraise their personal need for speciﬁc treatments relative
to their worries and concerns.
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Background: As the lifespan of patients with cystic ﬁbrosis (CF) increases so does
the incidence of multi-resistant organisms limiting options for optimal antibiotic
therapy. We have noted an increased incidence of reported adverse drug reactions
further restricting antibiotic choice for some individuals. In response we audited
the reporting of all adverse drug reactions within medical notes.
Method: Trust policy dictates that allergies are documented on the front sheet
with patient demographics. We looked through 193 (93%) sets of medical notes
for information from the front sheet and all places within the notes where adverse
reactions might be recorded. The audit included adult and paediatric patients.
Results: 126 (61%) patients overall had incorrect documentation. Frontsheets
indicated 19 reactions yet 131 were found within the medical notes. Results were
validated against patient understanding using a simple questionnaire and visual chart
of drugs with generic and proprietary names. Patients reported side effects that were
‘put up with’, yet could easily have been managed e.g. nausea and candidiasis. The
paediatric questionnaire has identiﬁed 31 new adverse reactions. So far signiﬁcantly
more have been identiﬁed in the adult population.
Conclusion: Front sheet documentation was not an accurate record of adverse
reactions and lacked detail. No clear distinction between allergic reactions and
manageable side effects suggests drugs may be excluded unnecessarily. A new
data sheet has been devised to document all allergies and side effects to drug
therapy with onset dates and details of avoidance or management. The success of
this will be reviewed at 6 monthly intervals.
